FOLX Health is a health and wellness platform that provides end-to-end virtual care for LGTBQIA+ populations. The company’s virtual care offerings include primary care, gender-affirming care (e.g., hormone replacement therapy, referrals to gender affirmation surgery), sexual and reproductive care, behavioral healthcare, and a community and content platform. FOLX members are seen by a clinician specializing in providing culturally competent, LGBTQIA+ specific care. Through the platform, consumers can obtain access to medications, labs, and supplies sent discretely to their homes.
Founded in 2019 by Executive Chair, A.G. Breitenstein, whose experiences with identity-based healthcare discrimination spawned the business, FOLX Health was incubated by Define Ventures. FOLX launched the first product, hormone replacement therapy (HRT), in March 2021 and has since scaled across the country, representing 90%+ of the addressable market.